CircFOXM1

ncRNA information

ncRNA name

CircFOXM1

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-1324/MECP2

Cancer information

Cancer name

Hepatocellular Carcinoma

Cancer site

qRT-PCR,Western blot

Treatment information

Treatment type

Chemotherapy

Drug

Sorafenib

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324

Tissue resource

pairs of fresh hepatocellular carcinomatissues and ANTs

hepatocellular carcinoma cell lines HepG2

hepatocellular carcinoma cell lines Huh-7

normal human liver cell lines LO2

Experiment

None


Institute

the Department of Hepato-Biliary Surgery, Dongguan People's Hospital, Southern Medical University

the Chinese Academy of Sciences Cell Bank Type Culture Collection

Country

China

China

Continent

Asia

Asia